We are live on ! Find out more
GC

Grimes & Company Portfolio holdings

AUM $4.62B
1-Year Est. Return 29.71%
This Fund
S&P 500
This Quarter Est. Return
+6.11%
1 Year Est. Return
+29.71%
3 Year Est. Return
+66.17%
5 Year Est. Return
+73.59%
10 Year Est. Return
+287.63%
AUM
$3.25B
AUM Growth
+$233M
Cap. Flow
+$71.7M
Cap. Flow %
2.21%
Top 10 Hldgs %
43.43%
Holding
357
New
26
Increased
176
Reduced
122
Closed
12
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
BCRX icon
251
BioCryst Pharmaceuticals
BCRX
$2.24B
$363K 0.01%
71,439
-916
-1% -$5.15K
HIPS icon
252
GraniteShares HIPS US High Income ETF
HIPS
$112M
$359K 0.01%
27,934
+703
+3% +$8.81K
IR icon
253
Ingersoll Rand
IR
$34.4B
$356K 0.01%
3,752
-3
-0.1% -$257
AZN icon
254
AstraZeneca
AZN
$245B
$354K 0.01%
2,613
-227
-8% -$30.1K
FE icon
255
FirstEnergy
FE
$28B
$348K 0.01%
9,000
SPYV icon
256
State Street SPDR Portfolio S&P 500 Value ETF
SPYV
$36.4B
$346K 0.01%
6,903
-99
-1% -$4.72K
IWP icon
257
iShares Russell Mid-Cap Growth ETF
IWP
$20.1B
$344K 0.01%
3,016
-170
-5% -$18.4K
BNY
258
Bank of New York Mellon
BNY
$106B
$334K 0.01%
+5,801
New +$319K
AZO icon
259
AutoZone
AZO
$48.8B
$333K 0.01%
106
-34
-24% -$97.2K
BIV icon
260
Vanguard Intermediate-Term Bond ETF
BIV
$28.8B
$332K 0.01%
4,398
+21
+0.5% +$1.58K
MTB icon
261
M&T Bank
MTB
$36.2B
$331K 0.01%
2,274
+328
+17% +$45.4K
IRWD icon
262
Ironwood Pharmaceuticals
IRWD
$728M
$329K 0.01%
37,759
-1,381
-4% -$16.8K
MU icon
263
Micron Technology
MU
$937B
$328K 0.01%
2,780
+39
+1% +$3.53K
IWY icon
264
iShares Russell Top 200 Growth ETF
IWY
$16.1B
$322K 0.01%
1,649
IJS icon
265
iShares S&P Small-Cap 600 Value ETF
IJS
$8.28B
$316K 0.01%
3,070
-722
-19% -$71.7K
FTSL icon
266
First Trust Senior Loan Fund ETF
FTSL
$2.32B
$312K 0.01%
6,752
-1
-0% -$46
MCK icon
267
McKesson
MCK
$96.8B
$312K 0.01%
580
-2
-0.3% -$1.01K
EPD icon
268
Enterprise Products Partners
EPD
$81.9B
$308K 0.01%
10,543
+285
+3% +$7.83K
MRNS
269
DELISTED
Marinus Pharmaceuticals, Inc
MRNS
$303K 0.01%
33,549
-751
-2% -$7.3K
LNG icon
270
Cheniere Energy
LNG
$54.1B
$300K 0.01%
1,858
+5
+0.3% +$804
ADMA icon
271
ADMA Biologics
ADMA
$2.03B
$299K 0.01%
45,267
FBIN icon
272
Fortune Brands Innovations
FBIN
$6.22B
$299K 0.01%
3,526
+10
+0.3% +$795
ODFL icon
273
Old Dominion Freight Line
ODFL
$44B
$292K 0.01%
1,333
+1
+0.1% +$209
COR icon
274
Cencora
COR
$60B
$291K 0.01%
1,197
+2
+0.2% +$460
FOLD
275
DELISTED
Amicus Therapeutics
FOLD
$285K 0.01%
24,223
-145
-0.6% -$1.85K

Similar funds

Grimes & Company's Q1 2024 Portfolio in Review

As of Q1 2024, Grimes & Company held 357 positions worth $3.25B, up 7.7% from $3.02B the previous quarter. Its ten largest holdings account for 43% of the portfolio.

Grimes & Company's Q1 2024 filing shows 26 new, 176 increased, 122 reduced and 12 closed positions. Its largest new stake was State Street Financial Select Sector SPDR ETF: 352,196 shares worth $14.8M. The largest sale was State Street Energy Select Sector SPDR ETF, an estimated $17.9M.

By sector, the portfolio is most concentrated in Technology at 14% of assets, up from 14% a quarter earlier, followed by Healthcare and Financials.

  • Grimes & Company's largest Q1 2024 buy was State Street Financial Select Sector SPDR ETF: 352,196 shares worth $14.8M.
  • Grimes & Company added most to State Street Consumer Discretionary Select Sector SPDR ETF in Q1 2024, an estimated $27.8M increase.
  • Grimes & Company's biggest Q1 2024 reduction was State Street Energy Select Sector SPDR ETF, cutting an estimated $17.9M.
  • Grimes & Company fully exited State Street SPDR S&P Biotech ETF in Q1 2024, selling an estimated $5.42M.
  • Grimes & Company's ten largest holdings make up 43% of its $3.25B portfolio in Q1 2024.
  • Grimes & Company opened 26 new positions and closed 12 in Q1 2024.
  • Grimes & Company's portfolio value rose 7.7% quarter-over-quarter to $3.25B.

Based on Grimes & Company's 13F filing for Q1 2024, filed 17 Apr 2024.